CN Patent

CN117838695A — 用于治疗骨髓增殖性肿瘤和与癌症相关的纤维化的pim激酶抑制剂

Assigned to Sumitomo Pharma Oncology Inc · Expires 2024-04-09 · 2y expired

What this patent protects

提供了治疗骨髓增殖性肿瘤和/或与癌症相关的纤维化的方法。公开的方法包括向需要其的哺乳动物施用PIM激酶抑制剂和可选的JAK激酶抑制剂或其他治疗剂。

USPTO Abstract

提供了治疗骨髓增殖性肿瘤和/或与癌症相关的纤维化的方法。公开的方法包括向需要其的哺乳动物施用PIM激酶抑制剂和可选的JAK激酶抑制剂或其他治疗剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN117838695A
Jurisdiction
CN
Classification
—
Expires
2024-04-09
Drug substance claim
No
Drug product claim
No
Assignee
Sumitomo Pharma Oncology Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.